Key Sessions
Nuno Fontes
Advances in process and manufacturing technology platforms for the industrialization of allogeneic cell therapy
Bayer U.S. LLC
Tiago Matos
Digital Transformation: Accelerating Process Development and Enhancing Control Strategies
Merck
Nathan Lewis, PhD
KEYNOTE: Achieving enhanced quality and quantity of biologics through multiplex genome editing
University of California, San Diego
Jacqualyn Schulman, Ph.D.
Engineering CHO Cells to improve a post-translational modification for a bispecific antibody production
Bristol-Myers Squibb
Justin Horvath
KEYNOTE: Case Study: Building A Flexible Facility for a Varied Portfolio
REGENXBIO Inc